Clinical trial
A Phase III, Randomized Trial of Surgical Resection With or Without BCG Versus Best Medical Therapy as Initial Treatment in Stage IV Melanoma
NCT01013623 is registered in ClinicalTrials.gov with Saint John's Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III, Randomized Trial of Surgical Resection With or Without BCG Versus Best Medical Therapy as Initial Treatment in Stage IV Melanoma
- Lead sponsor
- Saint John's Cancer Institute
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- November 30, 2009
- Completion date
- September 30, 2012
- Enrollment
- 12 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.
stage iv resectable melanoma